Sabina Berezowska

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil

119 publications

Sous presse | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
Pathology of Surgically Resected Lung Cancers Following Neoadjuvant Therapy.
Berezowska S., Keyter M., Bouchaab H., Weissferdt A. Advances in anatomic pathology. Peer-reviewed.
Swiss digital pathology recommendations: results from a Delphi process conducted by the Swiss Digital Pathology Consortium of the Swiss Society of Pathology.
Janowczyk A., Zlobec I., Walker C., Berezowska S., Huschauer V., Tinguely M., Kupferschmid J., Mallet T., Merkler D., Kreutzfeldt M. et al. Virchows Archiv. Peer-reviewed.
Morphologic Features of Invasion in Lung Adenocarcinoma: Diagnostic Pitfalls.
Thunnissen E., Noguchi M., Berezowska S., Papotti M.G., Filipello F., Minami Y., Blaauwgeers H. Advances in anatomic pathology. Peer-reviewed.
Isavuconazole for the Treatment of Fungal Infections: A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS).
Couchepin J., Reinhold I., Kronig I., Guidi M., Buclin T., Schreiber P.W., Neofytos D., Lamoth F., Fungal Infection Network of Switzerland (FUNGINOS), 2024/05. Open forum infectious diseases, 11 (5) pp. ofae223. Peer-reviewed.
Current challenges and practical aspects of molecular pathology for non-small cell lung cancers.
Hofman P., Berezowska S., Kazdal D., Mograbi B., Ilié M., Stenzinger A., Hofman V., 2024/02. Virchows Archiv, 484 (2) pp. 233-246. Peer-reviewed.
Genomic Staging of Multifocal Lung Squamous Cell Carcinomas Is Independent of the Comprehensive Morphologic Assessment.
Dacic S., Cao X., Bota-Rabassedas N., Sanchez-Espiridion B., Berezowska S., Han Y., Chung J.H., Beasley M.B., Dongmei L., Hwang D. et al., 2024/02. Journal of thoracic oncology, 19 (2) pp. 273-284. Peer-reviewed.
Impact of template-based synoptic reporting on completeness of surgical pathology reports.
Schaad N., Berezowska S., Perren A., Hewer E., 2024/01. Virchows Archiv, 484 (1) pp. 31-36. Peer-reviewed.
Pulmonary squamous cell carcinoma and lymphoepithelial carcinoma - morphology, molecular characteristics and differential diagnosis.
Berezowska S., Maillard M., Keyter M., Bisig B., 2024/01. Histopathology, 84 (1) pp. 32-49. Peer-reviewed.
Digital image analysis and artificial intelligence in pathology diagnostics-the Swiss view
Berezowska S., Cathomas G., Grobholz R., Henkel M., Jochum W., Koelzer V.H., Kreutzfeldt M., Mertz K.D., Rössle M., Soldini D. et al., 2023/12. Pathologie, 44 (Suppl 3) pp. 222-224. Peer-reviewed.
Pathologist Computer-Aided Diagnostic Scoring of Tumor Cell Fraction: A Swiss National Study.
Frei A.L., Oberson R., Baumann E., Perren A., Grobholz R., Lugli A., Dawson H., Abbet C., Lertxundi I., Reinhard S. et al., 2023/12. Modern pathology, 36 (12) p. 100335. Peer-reviewed.
Standardized Classification of Lung Adenocarcinoma Subtypes and Improvement of Grading Assessment Through Deep Learning.
Lami K., Ota N., Yamaoka S., Bychkov A., Matsumoto K., Uegami W., Munkhdelger J., Seki K., Sukhbaatar O., Attanoos R. et al., 2023/12. The American journal of pathology, 193 (12) pp. 2066-2079. Peer-reviewed.
Spatial metabolomics identifies distinct tumor-specific and stroma-specific subtypes in patients with lung squamous cell carcinoma.
Wang J., Sun N., Kunzke T., Shen J., Zens P., Prade V.M., Feuchtinger A., Berezowska S., Walch A., 2023/11/02. NPJ precision oncology, 7 (1) p. 114. Peer-reviewed.
International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy.
Dacic S., Travis W., Redman M., Saqi A., Cooper W.A., Borczuk A., Chung J.H., Glass C., Lopez J.M., Roden A.C. et al., 2023/10. Journal of thoracic oncology, 18 (10) pp. 1290-1302. Peer-reviewed.
Patterns of Carbon-Bound Exogenous Compounds Impact Disease Pathophysiology in Lung Cancer Subtypes in Different Ways.
Shen J., Sun N., Wang J., Zens P., Kunzke T., Buck A., Prade V.M., Wang Q., Feuchtinger A., Hu R. et al., 2023/09/12. ACS nano, 17 (17) pp. 16396-16411. Peer-reviewed.
Overcoming the Interobserver Variability in Lung Adenocarcinoma Subtyping: A Clustering Approach to Establish a Ground Truth for Downstream Applications.
Lami K., Bychkov A., Matsumoto K., Attanoos R., Berezowska S., Brcic L., Cavazza A., English J.C., Fabro A.T., Ishida K. et al., 2023/08/01. Archives of pathology & laboratory medicine, 147 (8) pp. 885-895. Peer-reviewed.
Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14.
König D., Savic Prince S., Hayoz S., Zens P., Berezowska S., Jochum W., Stauffer E., Braunersreuther V., Trachsel B., Thierstein S. et al., 2023/07/11. ESMO open, 8 (4) p. 101595. Peer-reviewed.
Deep computational image analysis of immune cell niches reveals treatment-specific outcome associations in lung cancer.
Barrera C., Corredor G., Viswanathan V.S., Ding R., Toro P., Fu P., Buzzy C., Lu C., Velu P., Zens P. et al., 2023/06/01. NPJ precision oncology, 7 (1) p. 52. Peer-reviewed.
Integrated longitudinal analysis of adult grade 4 diffuse gliomas with long-term relapse interval revealed upregulation of TGF-β signaling in recurrent tumors.
Kashani E., Schnidrig D., Gheinani A.H., Ninck M.S., Zens P., Maragkou T., Baumgartner U., Schucht P., Rätsch G., Rubin M.A. et al., 2023/04/06. Neuro-oncology, 25 (4) pp. 662-673. Peer-reviewed.
MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma.
Yang H., Gao Y., Xu D., Xu K., Liang S.Q., Yang Z., Scherz A., Hall SRR, Forster S., Berezowska S. et al., 2023/02/10. Cell death discovery, 9 (1) p. 55. Peer-reviewed.
Immunogenomic analysis of human brain metastases reveals diverse immune landscapes across genetically distinct tumors.
Álvarez-Prado Á.F., Maas R.R., Soukup K., Klemm F., Kornete M., Krebs F.S., Zoete V., Berezowska S., Brouland J.P., Hottinger A.F. et al., 2023/01/17. Cell reports. Medicine, 4 (1) p. 100900. Peer-reviewed.
Immunohistochemical Detection of the Autophagy Markers LC3 and p62/SQSTM1 in Formalin-Fixed and Paraffin-Embedded Tissue.
Berezowska S., Galván J.A., 2023. pp. 133-139 dans Histochemistry of Single Molecules, Springer.
Immunohistochemical Detection of the Chaperone-Mediated Autophagy Markers LAMP2A and HSPA8 in Formalin-Fixed and Paraffin-Embedded Tissues.
Losmanová T., Tschan M.P., Galván J.A., Berezowska S., 2023. pp. 141-147 dans Histochemistry of Single Molecules, Springer.
The effect of neoadjuvant therapy on PD-L1 expression and CD8+lymphocyte density in non-small cell lung cancer.
Zens P., Bello C., Scherz A., von Gunten M., Ochsenbein A., Schmid R.A., Berezowska S., 2022/12. Modern pathology, 35 (12) pp. 1848-1859. Peer-reviewed.
Major Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy.
Pataer A., Weissferdt A., Correa A.M., Vaporciyan A.A., Sepesi B., Heymach J.V., Berezowska S., Cascone T., Swisher S.G., 2022/11. JTO clinical and research reports, 3 (11) p. 100420. Peer-reviewed.
Programmed Death-Ligand 1 Expression in Lung Cancer and Paired Brain Metastases-a Single-Center Study in 190 Patients.
Kündig A., Zens P., Fung C., Scherz A., Cerciello F., Herrmann E., Ermis E., Schmid R.A., Vassella E., Berezowska S., 2022/11. JTO clinical and research reports, 3 (11) p. 100413. Peer-reviewed.
Image analysis reveals molecularly distinct patterns of TILs in NSCLC associated with treatment outcome.
Ding R., Prasanna P., Corredor G., Barrera C., Zens P., Lu C., Velu P., Leo P., Beig N., Li H. et al., 2022/06/03. NPJ precision oncology, 6 (1) p. 33. Peer-reviewed.
Spatial metabolomics for evaluating response to neoadjuvant therapy in non-small cell lung cancer patients.
Shen J., Sun N., Zens P., Kunzke T., Buck A., Prade V.M., Wang J., Wang Q., Hu R., Feuchtinger A. et al., 2022/06. Cancer communications, 42 (6) pp. 517-535. Peer-reviewed.
The Octopus Sign-A New HRCT Sign in Pulmonary Langerhans Cell Histiocytosis.
Poellinger A., Berezowska S., Myers J.L., Huber A., Funke-Chambour M., Guler S., Geiser T., Harari S., Caminati A., Zompatori M. et al., 2022/04/08. Diagnostics, 12 (4) p. 937. Peer-reviewed.
The cGAS-STING pathway drives type I IFN immunopathology in COVID-19.
Domizio J.D., Gulen M.F., Saidoune F., Thacker V.V., Yatim A., Sharma K., Nass T., Guenova E., Schaller M., Conrad C. et al., 2022/03. Nature, 603 (7899) pp. 145-151. Peer-reviewed.
COVID-19 Pulmonary Pathology: The Experience of European Pulmonary Pathologists throughout the First Two Waves of the Pandemic.
Fortarezza F., Pezzuto F., Hofman P., Kern I., Panizo A., von der Thüsen J., Timofeev S., Gorkiewicz G., Berezowska S., de Leval L. et al., 2022/01/01. Diagnostics, 12 (1) p. 95. Peer-reviewed.
Functional and molecular characterization of PD1<sup>+</sup> tumor-infiltrating lymphocytes from lung cancer patients.
Lipp J.J., Wang L., Yang H., Yao F., Harrer N., Müller S., Berezowska S., Dorn P., Marti T.M., Schmid R.A. et al., 2022. Oncoimmunology, 11 (1) p. 2019466. Peer-reviewed.
Tumor-infiltrating lymphocytes are functionally inactivated by CD90+ stromal cells and reactivated by combined Ibrutinib and Rapamycin in human pleural mesothelioma.
Yang H., Berezowska S., Dorn P., Zens P., Chen P., Peng R.W., Marti T.M., Kocher G.J., Schmid R.A., Hall SRR, 2022. Theranostics, 12 (1) pp. 167-185. Peer-reviewed.
Mutational profiles of primary pulmonary adenocarcinoma and paired brain metastases disclose the importance of KRAS mutations.
Vassella E., Kashani E., Zens P., Kündig A., Fung C., Scherz A., Herrmann E., Ermis E., Schmid R.A., Berezowska S., 2021/12. European journal of cancer, 159 pp. 227-236. Peer-reviewed.
Patterns of Carbon-Bound Exogenous Compounds in Patients with Lung Cancer and Association with Disease Pathophysiology.
Kunzke T., Prade V.M., Buck A., Sun N., Feuchtinger A., Matzka M., Fernandez I.E., Wuyts W., Ackermann M., Jonigk D. et al., 2021/12/01. Cancer research, 81 (23) pp. 5862-5875. Peer-reviewed.
Update Thoraxpathologie 2021 – Bericht der Arbeitsgemeinschaft [Update on thoracic pathology 2021-report of the working group thoracic pathology of the German Society of Pathology]
Berezowska S., Boor P., Jonigk D., Tischler V., 2021/12. Der Pathologe, 42 (Suppl 2) pp. 199-202. Peer-reviewed.
Chaperone-Mediated Autophagy Markers LAMP2A and HSPA8 in Advanced Non-Small Cell Lung Cancer after Neoadjuvant Therapy.
Losmanova T., Zens P., Scherz A., Schmid R.A., Tschan M.P., Berezowska S., 2021/10/13. Cells, 10 (10) p. 2731. Peer-reviewed.
Postmortem Cardiopulmonary Pathology in Patients with COVID-19 Infection: Single-Center Report of 12 Autopsies from Lausanne, Switzerland.
Berezowska S., Lefort K., Ioannidou K., Ndiaye D.R., Maison D., Petrovas C., Rotman S., Piazzon N., Milowich D., Sala N. et al., 2021/07/28. Diagnostics, 11 (8) p. 1357. Peer-reviewed.
A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancer.
Wang X., Bera K., Barrera C., Zhou Y., Lu C., Vaidya P., Fu P., Yang M., Schmid R.A., Berezowska S. et al., 2021/07. EBioMedicine, 69 p. 103481. Peer-reviewed.
A prognostic score for non-small cell lung cancer resected after neoadjuvant therapy in comparison with the tumor-node-metastases classification and major pathological response.
Zens P., Bello C., Scherz A., Koenigsdorf J., Pöllinger A., Schmid R.A., Ochsenbein A., Neppl C., Langer R., Berezowska S., 2021/07. Modern pathology, 34 (7) pp. 1333-1344. Peer-reviewed.
CRISPR-Mediated Kinome Editing Prioritizes a Synergistic Combination Therapy for FGFR1-Amplified Lung Cancer.
Yang Z., Liang S.Q., Yang H., Xu D., Bruggmann R., Gao Y., Deng H., Berezowska S., Hall SRR, Marti T.M. et al., 2021/06/01. Cancer research, 81 (11) pp. 3121-3133. Peer-reviewed.
Invasive Hormographiella aspergillata infection in patients with acute myeloid leukemia: Report of two cases successfully treated and review of the literature.
Tschopp J., Perentes J.Y., Beigelman-Aubry C., Berezowska S., Lovis A., Spertini O., Bochud P.Y., Lamoth F., 2021/06. Medical mycology case reports, 32 pp. 68-72. Peer-reviewed.
Frequency and Significance of Pathologic Pulmonary Findings in Postmortem Examinations-A Single Center Experience before COVID-19.
Berezowska S., Schmid A., Losmanová T., Trippel M., Blank A., Banz Y., Jakob S.M., Langer R., 2021/05/18. Diagnostics, 11 (5) p. 894. Peer-reviewed.
ALK inhibition activates LC3B-independent, protective autophagy in EML4-ALK positive lung cancer cells.
Schläfli A.M., Tokarchuk I., Parejo S., Jutzi S., Berezowska S., Engedal N., Tschan M.P., 2021/04/27. Scientific reports, 11 (1) p. 9011. Peer-reviewed.
Performance of a diagnostic algorithm for fibrotic hypersensitivity pneumonitis. A case-control study.
Guler S.A., Wohlfarth E., Berezowska S., Geiser T.K., Ebner L., Funke-Chambour M., 2021/04/23. Respiratory research, 22 (1) p. 120. Peer-reviewed.
Chemotherapy-induced CDA expression renders resistant non-small cell lung cancer cells sensitive to 5'-deoxy-5-fluorocytidine (5'-DFCR).
Gao Y., Zens P., Su M., Gemperli C.A., Yang H., Deng H., Yang Z., Xu D., Hall SRR, Berezowska S. et al., 2021/04/19. Journal of experimental & clinical cancer research, 40 (1) p. 138. Peer-reviewed.
Autochthonous Case of Pulmonary Histoplasmosis, Switzerland.
Schmiedel Y., Büchi A.E., Berezowska S., Pöllinger A., Mühlethaler K., Funke-Chambour M., 2021/03. Emerging infectious diseases, 27 (3) pp. 966-969. Peer-reviewed.
Pulmonary Histoplasmosis Mimicking Metastatic Lung Cancer: A Case Report.
Ruegg G., Zimmerli S., Trachsel M., Berezowska S., Engelbrecht S., Martin Y., Perrig M., 2021/02/17. Diagnostics, 11 (2) p. 328. Peer-reviewed.
Fibrosierte Hypersensitivitätspneumonie: Fokus auf pathologierelevante Aspekte der neuen klinischen Leitlinie der ATS/JRS/ALAT zur Diagnostik der Hypersensitivitätspneumonie bei Erwachsenen [Fibrotic hypersensitivity pneumonia: focus on pathology-relevant aspects of the new ATS/JRS/ALAT clinical guideline for the diagnosis of hypersensitivity pneumonia in adults]
Berezowska S., 2021/02. Der Pathologe, 42 (1) pp. 48-54. Peer-reviewed.
Thymic Hyperplasia with Lymphoepithelial Sialadenitis (LESA)-Like Features: Strong Association with Lymphomas and Non-Myasthenic Autoimmune Diseases.
Porubsky S., Popovic Z.V., Badve S., Banz Y., Berezowska S., Borchert D., Brüggemann M., Gaiser T., Graeter T., Hollaus P. et al., 2021/01/16. Cancers, 13 (2) p. 315. Peer-reviewed.
Corrigendum to "Chaperone-Mediated Autophagy Markers LAMP2A and HSC70 Are Independent Adverse Prognostic Markers in Primary Resected Squamous Cell Carcinomas of the Lung".
Losmanová T., Janser F.A., Humbert M., Tokarchuk I., Schläfli A.M., Neppl C., Schmid R.A., Tschan M.P., Langer R., Berezowska S., 2021. Oxidative medicine and cellular longevity, 2021 p. 9846486. Peer-reviewed.
Delta-Like Protein 3 Expression in Paired Chemonaive and Chemorelapsed Small Cell Lung Cancer Samples.
Kuempers C., Jagomast T., Krupar R., Paulsen F.O., Heidel C., Ribbat-Idel J., Idel C., Märkl B., Anlauf M., Berezowska S. et al., 2021. Frontiers in medicine, 8 p. 734901. Peer-reviewed.
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup>.
Klionsky D.J., Abdel-Aziz A.K., Abdelfatah S., Abdellatif M., Abdoli A., Abel S., Abeliovich H., Abildgaard M.H., Abudu Y.P., Acevedo-Arozena A. et al., 2021/01. Autophagy, 17 (1) pp. 1-382. Peer-reviewed.
Update Thoraxpathologie 2020 : Bericht der Arbeitsgemeinschaft [Update Thoracic Pathology 2020 : Report of the working group on thoracic pathology of the german society of pathology 2020]
Petersen I., Berezowska S., 2020/12. Der Pathologe, 41 (Suppl 2) pp. 184-186. Peer-reviewed.
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study.
Lu C., Bera K., Wang X., Prasanna P., Xu J., Janowczyk A., Beig N., Yang M., Fu P., Lewis J. et al., 2020/11. The Lancet. Digital health, 2 (11) pp. e594-e606. Peer-reviewed.
Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth.
Contat C., Ancey P.B., Zangger N., Sabatino S., Pascual J., Escrig S., Jensen L., Goepfert C., Lanz B., Lepore M. et al., 2020/06/23. eLife, 9 pp. e53618. Peer-reviewed.
Validation of the International Tumor Budding Consensus Conference (ITBCC) 2016 recommendation in squamous cell carcinoma of the lung-a single-center analysis of 354 cases.
Neppl C., Zlobec I., Schmid R.A., Berezowska S., 2020/05. Modern pathology, 33 (5) pp. 802-811. Peer-reviewed.
CD90 + CD146 + Identifies a Pulmonary Mesenchymal Cell Subtype With Both Immune Modulatory and Perivascular-Like Function in Postnatal Human Lung
Wang L., Dorn P., Zeinali S., Froment L., Berezowska S., Kocher G.J., Alves M.P., Brügger M., Esteves BIO, Blank F. et al., 2020/04/01. American journal of physiology. Lung cellular and molecular physiology, 318 (4) pp. L813-L830. Peer-reviewed.
Early and delayed neurological manifestations of cardiac myxomas.
Panos L.D., Brunel C., Berezowska S., Engisch R., Kollar A., Bassetti C., Sturzenegger M., Krestel H., 2020/03. Clinical neurology and neurosurgery, 190 p. 105673. Peer-reviewed.
CRISPR Screening Identifies WEE1 as a Combination Target for Standard Chemotherapy in Malignant Pleural Mesothelioma.
Xu D., Liang S.Q., Yang H., Bruggmann R., Berezowska S., Yang Z., Marti T.M., Hall SRR, Gao Y., Kocher G.J. et al., 2020/02. Molecular cancer therapeutics, 19 (2) pp. 661-672. Peer-reviewed.
Idiopathische Lungenfibrose – Epidemiologie, Ursachen und klinischer Verlauf [Idiopathic pulmonary fibrosis-epidemiology, causes, and clinical course]
Schäfer S.C., Funke-Chambour M., Berezowska S., 2020/02. Der Pathologe, 41 (1) pp. 46-51. Peer-reviewed.
Multidisziplinäre Diskussion – der Goldstandard der Diagnostik interstitieller Lungenerkrankungen [The multidisciplinary discussion-the gold standard in diagnosing interstitial lung diseases]
Berezowska S., Funke-Chambour M., Pöllinger A., Schäfer S.C., 2020/02. Der Pathologe, 41 (1) pp. 14-20. Peer-reviewed.
Chaperone-Mediated Autophagy Markers LAMP2A and HSC70 Are Independent Adverse Prognostic Markers in Primary Resected Squamous Cell Carcinomas of the Lung.
Losmanová T., Janser F.A., Humbert M., Tokarchuk I., Schläfli A.M., Neppl C., Schmid R.A., Tschan M.P., Langer R., Berezowska S., 2020. Oxidative medicine and cellular longevity, 2020 p. 8506572. Peer-reviewed.
Respiratory Failure Due to Rapidly Progressive Metastatic Lung Calcifications after Heart Transplantation in a 6-Year-Old Girl.
Berezowska S., Poellinger A., Ulmer F., Trippel M., 2019/11/01. American journal of respiratory and critical care medicine, 200 (9) pp. 1177-1178. Peer-reviewed.
Endoplasmic Reticulum Stress Signaling as a Therapeutic Target in Malignant Pleural Mesothelioma.
Xu D., Yang H., Yang Z., Berezowska S., Gao Y., Liang S.Q., Marti T.M., Hall SRR, Dorn P., Kocher G.J. et al., 2019/10/08. Cancers, 11 (10). Peer-reviewed.
Secreting clear cell tumour of the parathyroid.
Bräutigam K., Kaderli R., Berezowska S., 2019/08/19. BMJ case reports, 12 (8). Peer-reviewed.
PD-L1 testing of non-small cell lung cancer using different antibodies and platforms: a Swiss cross-validation study.
Savic S., Berezowska S., Eppenberger-Castori S., Cathomas G., Diebold J., Fleischmann A., Jochum W., Komminoth P., McKee T., Letovanec I. et al., 2019/07. Virchows Archiv, 475 (1) pp. 67-76. Peer-reviewed.
Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549.
Tièche C.C., Gao Y., Bührer E.D., Hobi N., Berezowska S.A., Wyler K., Froment L., Weis S., Peng R.W., Bruggmann R. et al., 2019/02. Neoplasia, 21 (2) pp. 185-196. Peer-reviewed.
Comparison of the 7th and 8th Edition of the UICC/AJCC TNM Staging System in Primary Resected Squamous Cell Carcinomas of the Lung-A Single Center Analysis of 354 Cases.
Neppl C., Keller M.D., Scherz A., Dorn P., Schmid R.A., Zlobec I., Berezowska S., 2019. Frontiers in medicine, 6 p. 196. Peer-reviewed.
Diagnostik interstitieller Lungenerkrankungen im multidisziplinären Team [Diagnostics of interstitial lung diseases in the multidisciplinary team]
Berezowska S., Pöllinger A., Funke-Chambour M., 2019. Therapeutische Umschau. Revue therapeutique, 76 (7) pp. 375-381. Peer-reviewed.
mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer.
Liang S.Q., Bührer E.D., Berezowska S., Marti T.M., Xu D., Froment L., Yang H., Hall SRR, Vassella E., Yang Z. et al., 2019/01. Oncogene, 38 (5) pp. 622-636. Peer-reviewed.
Lungenkrebs unter Stress [Lung cancer under stress]
Berezowska S., 2018/12. Der Pathologe, 39 (Suppl 2) pp. 208-214. Peer-reviewed.
Advancing synoptic cancer reports beyond English: the University of Bern/PathoLink approach.
Banz Y., Berezowska S., de Leval L., Rubbia-Brandt L., Tolnay M., Moch H., Perren A., Hewer E., 2018/11. Virchows Archiv, 473 (5) pp. 655-656. Peer-reviewed.
Fatal Measles Virus Infection After Rituximab-Containing Chemotherapy in a Previously Vaccinated Patient.
Jent P., Trippel M., Frey M., Pöllinger A., Berezowska S., Langer R., Furrer H., Béguelin C., 2018/11. Open forum infectious diseases, 5 (11) pp. ofy244. Peer-reviewed.
Expression Analysis of Autophagy Related Markers LC3B, p62 and HMGB1 Indicate an Autophagy-Independent Negative Prognostic Impact of High p62 Expression in Pulmonary Squamous Cell Carcinomas.
Langer R., Neppl C., Keller M.D., Schmid R.A., Tschan M.P., Berezowska S., 2018/08/21. Cancers, 10 (9). Peer-reviewed.
Identification of a MET-eIF4G1 translational regulation axis that controls HIF-1α levels under hypoxia.
Glück A.A., Orlando E., Leiser D., Poliaková M., Nisa L., Quintin A., Gavini J., Stroka D.M., Berezowska S., Bubendorf L. et al., 2018/07. Oncogene, 37 (30) pp. 4181-4196. Peer-reviewed.
Increased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesothelioma.
Xu D., Liang S.Q., Yang H., Lüthi U., Riether C., Berezowska S., Marti T.M., Hall SRR, Bruggmann R., Kocher G.J. et al., 2018/07. British journal of cancer, 119 (1) pp. 65-75. Peer-reviewed.
High-Resolution Tissue Mass Spectrometry Imaging Reveals a Refined Functional Anatomy of the Human Adult Adrenal Gland.
Sun N., Wu Y., Nanba K., Sbiera S., Kircher S., Kunzke T., Aichler M., Berezowska S., Reibetanz J., Rainey W.E. et al., 2018/03/01. Endocrinology, 159 (3) pp. 1511-1524. Peer-reviewed.
Pulmonary Fibrous Nodule with Ossifications May Indicate Vascular Ehlers-Danlos Syndrome with Missense Mutation in COL3A1.
Berezowska S., Christe A., Bartholdi D., Koch M., von Garnier C., 2018/03/01. American journal of respiratory and critical care medicine, 197 (5) pp. 661-662. Peer-reviewed.
A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas.
Adams O., Janser F.A., Dislich B., Berezowska S., Humbert M., Seiler C.A., Kroell D., Slotta-Huspenina J., Feith M., Ott K. et al., 2018. PloS one, 13 (6) pp. e0197610. Peer-reviewed.
Adverse prognostic value of PD-L1 expression in primary resected pulmonary squamous cell carcinomas and paired mediastinal lymph node metastases.
Keller M.D., Neppl C., Irmak Y., Hall S.R., Schmid R.A., Langer R., Berezowska S., 2018/01. Modern pathology, 31 (1) pp. 101-110. Peer-reviewed.
Idiopathic pulmonary fibrosis in a Swiss interstitial lung disease reference centre.
Guler S., Zumstein P., Berezowska S., Pöllinger A., Geiser T., Funke-Chambour M., 2018. Swiss medical weekly, 148 pp. w14577. Peer-reviewed.
Increased Expiratory Computed Tomography Density Reveals Possible Abnormalities in Radiologically Preserved Lung Parenchyma in Idiopathic Pulmonary Fibrosis.
Petroulia V., Funke M., Zumstein P., Berezowska S., Ebner L., Geiser T., Torbica N., Heverhagen J., Poellinger A., 2018/01. Investigative radiology, 53 (1) pp. 45-51. Peer-reviewed.
Prognostic value of MIB-1 proliferation index in solitary fibrous tumors of the pleura implemented in a new score - a multicenter study.
Diebold M., Soltermann A., Hottinger S., Haile S.R., Bubendorf L., Komminoth P., Jochum W., Grobholz R., Theegarten D., Berezowska S. et al., 2017/12/16. Respiratory research, 18 (1) p. 210. Peer-reviewed.
Diagnostic implications of TERT promoter mutation status in diffuse gliomas in a routine clinical setting.
Hewer E., Prebil N., Berezowska S., Gutt-Will M., Schucht P., Dettmer M.S., Vassella E., 2017/11. Virchows Archiv, 471 (5) pp. 641-649. Peer-reviewed.
Low co-expression of epidermal growth factor receptor and its chaperone heat shock protein 90 is associated with worse prognosis in primary glioblastoma, IDH-wild-type.
Sartori E., Langer R., Vassella E., Hewer E., Schucht P., Zlobec I., Berezowska S., 2017/10. Oncology reports, 38 (4) pp. 2394-2400. Peer-reviewed.
Increased PD-L1 expression and IL-6 secretion characterize human lung tumor-derived perivascular-like cells that promote vascular leakage in a perfusable microvasculature model.
Bichsel C.A., Wang L., Froment L., Berezowska S., Müller S., Dorn P., Marti T.M., Peng R.W., Geiser T., Schmid R.A. et al., 2017/09/06. Scientific reports, 7 (1) p. 10636. Peer-reviewed.
Expression analysis of LC3B and p62 indicates intact activated autophagy is associated with an unfavorable prognosis in colon cancer.
Niklaus M., Adams O., Berezowska S., Zlobec I., Graber F., Slotta-Huspenina J., Nitsche U., Rosenberg R., Tschan M.P., Langer R., 2017/08/15. Oncotarget, 8 (33) pp. 54604-54615. Peer-reviewed.
Expression patterns of programmed death-ligand 1 in esophageal adenocarcinomas: comparison between primary tumors and metastases.
Dislich B., Stein A., Seiler C.A., Kröll D., Berezowska S., Zlobec I., Galvan J., Slotta-Huspenina J., Walch A., Langer R., 2017/06. Cancer immunology, immunotherapy, 66 (6) pp. 777-786. Peer-reviewed.
Successful Treatment of Pituitary Germinoma with Etoposide, Cisplatin, Vincristine, Methotrexate and Bleomycin Chemotherapy Without Radiotherapy.
Scherz A., Feller K., Berezowska S., Genitsch V., Zweifel M., 2017/06. Anticancer research, 37 (6) pp. 3111-3115. Peer-reviewed.
Glycine decarboxylase and HIF-1α expression are negative prognostic factors in primary resected early-stage non-small cell lung cancer.
Berezowska S., Galván J.A., Langer R., Bubendorf L., Savic S., Gugger M., Schmid R.A., Marti T.M., 2017/03. Virchows Archiv, 470 (3) pp. 323-330. Peer-reviewed.
Immunohistochemical Detection of the Autophagy Markers LC3 and p62/SQSTM1 in Formalin-Fixed and Paraffin-Embedded Tissue
Berezowska Sabina, Galván José A., 2017. pp. 189-194 dans Methods in Molecular Biology, Springer New York.
Pleural Biopsies: Just Freeze It?
Berezowska S., von Garnier C., 2017. Respiration; international review of thoracic diseases, 94 (1) pp. 16-17. Peer-reviewed.
Questioning the role of selected somatic PIK3C2B mutations in squamous non-small cell lung cancer oncogenesis.
Kind M., Klukowska-Rötzler J., Berezowska S., Arcaro A., Charles R.P., 2017. PloS one, 12 (10) pp. e0187308. Peer-reviewed.
Trockener Husten und Leistungsknick
Wohlfarth Eva, Berezowska Sabina, Pöllinger Andreas, Geiser Thomas, Funke Manuela, 2016/11/22. Forum Médical Suisse ‒ Swiss Medical Forum, 16 (47).
miR-29b Mediates NF-κB Signaling in KRAS-Induced Non-Small Cell Lung Cancers.
Langsch S., Baumgartner U., Haemmig S., Schlup C., Schäfer S.C., Berezowska S., Rieger G., Dorn P., Tschan M.P., Vassella E., 2016/07/15. Cancer research, 76 (14) pp. 4160-4169. Peer-reviewed.
Prognostic relevance of autophagy markers LC3B and p62 in esophageal adenocarcinomas.
Adams O., Dislich B., Berezowska S., Schläfli A.M., Seiler C.A., Kröll D., Tschan M.P., Langer R., 2016/06/28. Oncotarget, 7 (26) pp. 39241-39255. Peer-reviewed.
Prognostic value of the autophagy markers LC3 and p62/SQSTM1 in early-stage non-small cell lung cancer.
Schläfli A.M., Adams O., Galván J.A., Gugger M., Savic S., Bubendorf L., Schmid R.A., Becker K.F., Tschan M.P., Langer R. et al., 2016/06/28. Oncotarget, 7 (26) pp. 39544-39555. Peer-reviewed.
Fulminant hepatic and multiple organ failure following acute viral tonsillitis: a case report.
Bechtel-Grosch U., Beguelin C., Berezowska S., Dufour J.F., Takala J., Schefold J.C., 2016/01/20. Journal of medical case reports, 10 p. 7. Peer-reviewed.
Combined ATRX/IDH1 immunohistochemistry predicts genotype of oligoastrocytomas.
Hewer E., Vajtai I., Dettmer M.S., Berezowska S., Vassella E., 2016/01. Histopathology, 68 (2) pp. 272-278. Peer-reviewed.
Histopathologische und radiologische Korrelationen [Interstitial pneumonias--Histopathological and radiological correlation]
Berezowska S., Pöllinger A., 2016. Therapeutische Umschau. Revue therapeutique, 73 (1) pp. 11-17. Peer-reviewed.
Multidisciplinary discussion for diagnosis of interstitial lung disease in real life.
Guler S.A., Berezowska S.A., Christe A., Geiser T., Funke-Chambour M., 2016. Swiss medical weekly, 146 pp. w14318. Peer-reviewed.
Eosinophile Enteritis als seltene Ursache von Bauchschmerzen
Blanc Buehlmann Andrea, Rodondi Nicolas, Berezowska Sabina, Marti Grischa, 2015/10/13. Forum Médical Suisse ‒ Swiss Medical Forum, 15 (42) pp. 962–964.
Sacroiliac Coalition: First Description and Report of a Successful Resection
Greiner Axel, Baur-Melnyk Andrea, Berezowska Sabina, D'Anastasi Melvin, Birkenmaier Christof, 2015/10. Global Spine Journal, 5 (5) pp. 48-51.
Seltener endobronchialer Befund
Graf Lukas, El-Hag Karin, Berezowska Sabina, 2015/09/15. Forum Médical Suisse ‒ Swiss Medical Forum, 15 (38) pp. 854-855.
Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer.
Liang S.Q., Marti T.M., Dorn P., Froment L., Hall S.R., Berezowska S., Kocher G., Schmid R.A., Peng R.W., 2015/07/16. Cell death & disease, 6 pp. e1824. Peer-reviewed.
Reliable LC3 and p62 autophagy marker detection in formalin fixed paraffin embedded human tissue by immunohistochemistry.
Schläfli A.M., Berezowska S., Adams O., Langer R., Tschan M.P., 2015/05/05. European journal of histochemistry, 59 (2) p. 2481. Peer-reviewed.
Primary intramedullary melanocytoma in the cervical spinal cord: Case report and literature review.
Wagner F., Berezowska S., Wiest R., Gralla J., Beck J., Verma R.K., Huber A., 2015. Radiology case reports, 10 (1) p. 1010. Peer-reviewed.
When Malignancies Mimic Interstitial Lung Disease: A Case Series and Review of the Literature
Guler S., Berezowska S., Christe A., Funke M., Geiser T., 2015/01/01. Journal of Clinical Respiratory Diseases and Care, 1 (1) pp. 1-3.
Expression analysis of heat shock protein 90 (HSP90) and Her2 in colon carcinoma.
Drecoll E., Nitsche U., Bauer K., Berezowska S., Slotta-Huspenina J., Rosenberg R., Langer R., 2014/06. International journal of colorectal disease, 29 (6) pp. 663-671. Peer-reviewed.
Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis.
Berezowska S., Flaig M.J., Ruëff F., Walz C., Haferlach T., Krokowski M., Kerler R., Petat-Dutter K., Horny H.P., Sotlar K., 2014/01. Modern pathology, 27 (1) pp. 19-29. Peer-reviewed.
Epidermal growth factor receptor, phosphatidylinositol-3-kinase catalytic subunit/PTEN, and KRAS/NRAS/BRAF in primary resected esophageal adenocarcinomas: loss of PTEN is associated with worse clinical outcome.
Bettstetter M., Berezowska S., Keller G., Walch A., Feuchtinger A., Slotta-Huspenina J., Feith M., Drecoll E., Höfler H., Langer R., 2013/05. Human pathology, 44 (5) pp. 829-836. Peer-reviewed.
Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.
Berezowska S., Novotny A., Bauer K., Feuchtinger A., Slotta-Huspenina J., Becker K., Langer R., Walch A., 2013. PloS one, 8 (7) pp. e69098. Peer-reviewed.
Loss of TRAIL-receptors is a recurrent feature in pancreatic cancer and determines the prognosis of patients with no nodal metastasis after surgery.
Gallmeier E., Bader D.C., Kriegl L., Berezowska S., Seeliger H., Göke B., Kirchner T., Bruns C., De Toni E.N., 2013. PloS one, 8 (2) pp. e56760. Peer-reviewed.
Akuter Innenohrausfall mit Fazialisparese und starker Cephalgie [Acute inner ear loss with facial paresis and severe headache]
Schrötzlmair F., Kisser U., Altmann T., Berezowska S., Ertl-Wagner B., Müller J., 2012/12. Laryngo- rhino- otologie, 91 (12) pp. 791-793. Peer-reviewed.
Surgical pathology in sub-Saharan Africa--volunteering in Malawi.
Berezowska S., Tomoka T., Kamiza S., Milner D.A., Langer R., 2012/04. Virchows Archiv, 460 (4) pp. 363-370. Peer-reviewed.
Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis.
Sotlar K., Cerny-Reiterer S., Petat-Dutter K., Hessel H., Berezowska S., Müllauer L., Valent P., Horny H.P., 2011/04. Modern pathology, 24 (4) pp. 585-595. Peer-reviewed.
Targeting ErbB receptors in high-grade glioma.
Berezowska S., Schlegel J., 2011. Current pharmaceutical design, 17 (23) pp. 2468-2487. Peer-reviewed.
Effect of additional inhibition of human epidermal growth factor receptor 2 with the bispecific tyrosine kinase inhibitor AEE788 on the resistance to specific EGFR inhibition in glioma cells.
Berezowska S., Diermeier-Daucher S., Brockhoff G., Busch R., Duyster J., Grosu A.L., Schlegel J., 2010/11. International journal of molecular medicine, 26 (5) pp. 713-721. Peer-reviewed.
Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD).
Sotlar K., Colak S., Bache A., Berezowska S., Krokowski M., Bültmann B., Valent P., Horny H.P., 2010/04. The Journal of pathology, 220 (5) pp. 586-595. Peer-reviewed.
Unicentre - CH-1015 Lausanne
Tél. +41 21 692 11 11
Swiss University